loader image
Sunday, February 23, 2025
43.5 F
McAllen
We Welcome your Press Release
- Advertisement -

Jalapeno Golf Classic Hole in One prizes

Translate to Spanish or other 102 languages!

Mega Doctor News

- Advertisement -

Golfers are coming in from Austin and Corpus Christi to play in the annual RGV Hispanic Chamber’s “Jalapeno Golf Classic” scheduled for Thursday Oct. 16th at Palm View Golf Course in McAllen.  Prizes include Longest Drive and Closest to the Pin as well as Hole – In- One sponsors South Texas Buick GMC, a Rolex watch from Deutsch & Deutsch, Clark Knapp Honda and Frank Smith Toyota.  Golfers will get to have lunch as they register at 12:00 noon.  The 4 man tournament will tee off at 1:00pm.  A dinner will also be provided at the Awards Presentation.

Golfers will get snacks and beverages out on the course, as well as massages during and after they finish their play.

1st Place team will win $1000, 2nd place $750 and 3rd place $500.  Other great door prizes will also be provided as well as 2 tickets on Southwest Airlines.  Teams are $500, Hole sponsors are $100, and sponsorships are:  shirt $5000, Cap $3,000,  golf balls $2,000, Goody Bags $2,000 and Towel $1,500.  There are only a few team openings left.

- Advertisement -

For more information call the RGVHCC at 928-0060.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

UPDATE: Measles Outbreak

Mega Doctor News Mega Doctor News  As of February 18, 2025, the Texas...

DHR Health Celebrates 100th Ion Robotic-Assisted Bronchoscopy

DHR Health, a leader in healthcare serving the Rio Grande Valley, announced today that Dr. Federico Vallejo, pulmonologist, has successfully performed his 100th Ion robotic-assisted bronchoscopy.

DHR Health: Pioneering Alzheimer’s Treatment Breakthrough South of San Antonio

DHR Health, a leader in healthcare innovation, proudly announced today its groundbreaking achievement as the first hospital south of San Antonio to successfully administer Leqembi, an FDA-approved medication for the early treatment of Alzheimer’s disease. This milestone demonstrates their expertise and is a significant advancement in healthcare for the Rio Grande Valley.

FDA Approves First CRISPR Gene Therapy to Treat Sickle Cell Disease

Today, the U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene therapies for the treatment of sickle cell disease (SCD) in patients 12 years and older.
- Advertisement -
×